Heterogeneity of Drug Target Expression Among Metastatic Lesions: Lessons from a Breast Cancer Autopsy Program
Open Access
- 15 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (12) , 3643-3645
- https://doi.org/10.1158/1078-0432.ccr-08-1135
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal MetastasesClinical Cancer Research, 2008
- Metastasis: a therapeutic target for cancerNature Clinical Practice Oncology, 2008
- Breast cancer metastases are molecularly distinct from their primary tumorsOncogene, 2007
- Changes in and Prognostic Value of Hormone Receptor Status in a Series of Operable Breast Cancer Patients Treated with Neoadjuvant ChemotherapyThe Oncologist, 2007
- A gene expression signature associated with metastatic cells in effusions of breast carcinoma patientsInternational Journal of Cancer, 2007
- Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implicationsMolecular Oncology, 2007
- Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast CancerCancer Research, 2005
- Biological characteristics of breast cancer at the primary tumour and the involved lymph nodesInternational Journal Of Clinical Practice, 2005
- Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysisCancer, 2004
- Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node‐positive breast cancer and its implications in patient outcomeJournal of Surgical Oncology, 2003